The global uveitis treatment market is growing at a significant CAGR of around 6.1% during the forecast period (2020-2026). Uveitis is a form of inflammation that occurs in the middle layer of the eye. Firstly, it developed swelling, redness, and pain in the eye, and if left untreated, it can even lead to permanent loss of vision. According to the Prevent Blindness, the uveitis causes around 30,000 new cases of blindness every year in the US. Therefore, the uveitis treatment market is expected to project a modest growth rate during the forecast period. There are several factors that will support the growth of the global market, such as rising prevalence of autoimmune disorder and infectious diseases. This, in turn, is rising the prevalence of uveitis across the globe. 

Moreover, there are several other pivotal factors that are estimated to drive the global uveitis treatment market during the forecast period, such as range of products under clinical trials, introduction of novel delivery system, and growing medical tourism in emerging economies. For instance, in May 2018, Clearside Biomedical Inc. introduced novel drug therapy for the treatment of back-of-the-eye diseases. The company announced the attainment for the positive topline results from its new Phase 3 clinical trial of suprachoroidal CLS-TA in patients dealing with macular edema associated with non-infectious uveitis.

Segmental Outlook  

The uveitis treatment market is classified on the basis of diseases type and treatment type. Based on disease type, the market is segmented into anterior uveitis, posterior uveitis, intermediate uveitis, and pan uveitis. Based on treatment type, the market is segmented into corticosteroids immunosuppressant, monoclonal antibodies, cycloplegics, and others. 

Global Uveitis treatment Market Share by Disease Type, 2019 (%)

The global uveitis treatment market is driven by rising prevalence of anterior uveitis

The demand for the anterior uveitis treatment is significant across the globe. Acute anterior uveitis is the most common form of uveitis, having significant occurrence rate in middle aged and young people. There are several diseases that are associated with the acute anterior uveitis, such as colitis or bowel inflammation, relapsing polychondritis, and vasculitis, among others. The prevalence of such diseases leads to the development of acute anterior uveitis, which is lately can be treated with corticosteroids drops. Moreover, some of the acute anterior uveitis may recur, owing to which, the demand for anterior uveitis treatment is high across the globe.

Regional Outlook 

The global uveitis treatment market is classified on the basis of geography, which includes North America, Europe, Asia-Pacific, and Rest of the World. North America holds a significant share in the global uveitis treatment market. The US plays the critical role in geographic contribution of North America in global uveitis treatment market, attributed to the development of advanced healthcare infrastructure and presence of several healthcare regulatory organizations in the region. Moreover, the significant presence of market players in the US such as AbbVie Inc., Alimera Sciences, Inc., and Santen Pharmaceutical Co., Ltd, is driving the market growth in North America. 

The significant prevalence of uveitis in the US is offering growth in the demand for uveitis treatment. According to the Ocular Immunology and Uveitis Foundation, an estimated prevalence of uveitis in the US is around 38 cases per 100,000 population, whereas, the incidence rate is 15 cases per 100,000 population. Moreover, there are around 11,000 cases of pediatric uveitis in the US, with 4,300 new cases occurring each year, as per the same source. Such large population dealing with uveitis in the country is augmenting the need for its treatment, which in turn, is driving the uveitis treatment market in the region. 

Global Uveitis treatment Market Growth, by Region 2020-2026

Asia-Pacific is expected to propel with a considerable growth rate in the global market

Asia-Pacific is estimated to project a considerable CAGR in the global uveitis treatment market. Countries in Asia-Pacific that are contributing to the market growth include China, India, and Japan. The market is driven by the rising prevalence of infectious diseases and the government support to cater these diseases. Moreover, the gradual improvement in the healthcare infrastructure with the growing governmental spending is estimated to project a growth to the uveitis treatment market during the forecast period. The medical tourism will further play a significant role in offering growth to the market in the region. VISION 2020- The Right to Sight initiative started by the Government of India aims to eliminate avoidable blindness by 2020. It is a key driver of the World Health Organization (WHO) and the International Agency for the Prevention of Blindness (IAPB) joint global initiative for eliminating avoidable blindness.

Market Players Outlook

The key players in the uveitis treatment market are contributing significantly by providing advanced technology-based products and through expanding their geographical presence across the globe. The key players operating in the global uveitis treatment market include AbbVie Inc., Alimera Sciences, Inc., Santen Pharmaceutical Co., Ltd., Allergan PLC, Cadila Pharmaceuticals Ltd., and EyePoint Pharmaceuticals, Inc. These market players adopt various strategies such as product launch, partnerships, collaborations, merger, and acquisitions to sustain a strong position in the market. 

The Report Covers

• Market value data analysis of 2019 and forecast to 2026.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the global uveitis treatment market. Based on the availability of data, information related to pipeline products, and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying ‘who-stands-where’ in the market.